Rohit S Loomba1, Karan Nijhawan2, Robert Anderson3. 1. Division of Cardiology, Children's Hospital of Wisconsin/Medical College of Wisconsin, Milwaukee, WI, USA loomba.rohit@gmail.com. 2. Department of Medicine, Rush University Medical Center, Chicago, IL, USA. 3. Institute of Genetic Medicine, Newcastle University, United Kingdom.
Abstract
BACKGROUND: Heterotaxy has been demonstrated to reduce survival. There are several different subgroups of patients, however, and no single study has had a large number of patients and analyzed survival across the different subgroups such as patients born in different eras, patients with right and left isomerism, and patients with biventricular or functionally univentricular hearts. This study pools previously reported data from Kaplan-Meier curves and performs such subgroup analysis. METHODS: A systematic review of the literature was performed to identify studies reporting survival of patients with the so-called "heterotaxy" by means of Kaplan-Meier survival curves. Data were extracted from these survival curves and then pooled together. A polynomial regression was then used to generate a pooled survival curve. This was done for all patients, those born in a more recent era, those with right and left isomerism, and those with biventricular or functionally univentricular hearts. RESULTS: Those born in the more recent era (after 2000) had increased survival compared to the overall cohort. Those with left isomerism tended to have a survival benefit compared to those with right isomerism until about 16 years of age, beyond which those with right isomerism developed a survival benefit. Those with biventricular hearts had a survival benefit compared to those with left isomerism. CONCLUSION: Survival in the so-called heterotaxy syndrome is based on several factors, which include era of birth, sidedness of isomerism, and whether the heart is biventricular or functionally univentricular.
BACKGROUND: Heterotaxy has been demonstrated to reduce survival. There are several different subgroups of patients, however, and no single study has had a large number of patients and analyzed survival across the different subgroups such as patients born in different eras, patients with right and left isomerism, and patients with biventricular or functionally univentricular hearts. This study pools previously reported data from Kaplan-Meier curves and performs such subgroup analysis. METHODS: A systematic review of the literature was performed to identify studies reporting survival of patients with the so-called "heterotaxy" by means of Kaplan-Meier survival curves. Data were extracted from these survival curves and then pooled together. A polynomial regression was then used to generate a pooled survival curve. This was done for all patients, those born in a more recent era, those with right and left isomerism, and those with biventricular or functionally univentricular hearts. RESULTS: Those born in the more recent era (after 2000) had increased survival compared to the overall cohort. Those with left isomerism tended to have a survival benefit compared to those with right isomerism until about 16 years of age, beyond which those with right isomerism developed a survival benefit. Those with biventricular hearts had a survival benefit compared to those with left isomerism. CONCLUSION: Survival in the so-called heterotaxy syndrome is based on several factors, which include era of birth, sidedness of isomerism, and whether the heart is biventricular or functionally univentricular.
Authors: Rohit S Loomba; Michael Danduran; Kim G Nielsen; Astrid M Ring; Joshua Kovach; Robert H Anderson Journal: Pediatr Cardiol Date: 2016-11-23 Impact factor: 1.655
Authors: Diego B Ortega-Zhindón; Iris P Flores-Sarria; María A Minakata-Quiróga; Stephanie T Angulo-Cruzado; Luis A Romero-Montalvo; Jorge L Cervantes-Salazar Journal: Arch Cardiol Mex Date: 2021-11-01
Authors: Elisabeth Seidl-Mlczoch; Gregor Kasprian; Erwin Kitzmueller; Daniel Zimpfer; Irene Steiner; Victoria Jowett; Marlene Stuempflen; Alice Wielandner; Barbara Ulm; Ina Michel-Behnke Journal: Front Pediatr Date: 2022-07-14 Impact factor: 3.569
Authors: Catherine C Pickin; James Castle; Vibha Shaji; Adeolu Banjoko; Aimee-Louise Chambault; Anna N Seale; Anthony Lander; Chetan Mehta; Adrian Crucean Journal: J Cardiovasc Dev Dis Date: 2021-03-28